Chronic Leptin Infusion Increases Arterial Pressure

Eugene W. Shek, Michael W. Brands, John E. Hall

Research output: Contribution to journalArticle

611 Citations (Scopus)

Abstract

Plasma leptin concentration is increased in hypertensive obese humans, but whether leptin contributes to the increased arterial pressure in obesity is not known. In this study, we tested whether chronic increases in leptin, to levels comparable to those in obesity, could cause a sustained increase in arterial pressure and also the importance of central nervous system (CNS) versus systemic mechanisms. Five male Sprague-Dawley rats were implanted with chronic nonoccluding catheters in the abdominal aorta and both carotid arteries for CNS infusion, and five other rats were implanted with an abdominal aorta catheter and femoral vein catheter for intravenous (IV) infusion. After 7 days of control, leptin was infused into the carotid arteries or femoral vein at 0.1 micro gram/kg/min for 5 days and 1.0 micro gram/kg/min for 7 days, followed by a 7-day recovery period. The carotid artery and IV infusions of leptin at 1 micro gram/kg/min significantly increased plasma leptin levels, from 1.2 +/- 0.4 ng/mL to 91 +/- 5 ng/mL and from 0.9 +/- 0.1 ng/mL to 94 +/- 9 ng/mL, respectively, but there was no significant increase in either group at the low dose. Food intake also did not change at the low dose but decreased by approximately 65% in the carotid group and 69% in the IV group after 7 days of the 1 micro gram/kg/min infusion. Mean arterial pressure (MAP) increased slightly at the low dose only in the carotid group, but this was not statistically significant. At the higher dose, however, MAP increased significantly from 86 +/- 1 mm Hg to 94 +/- 1 mm Hg in the carotid group and from 87 +/- 1 mm Hg to 93 +/- 1 mm Hg in the IV group. Heart rate also increased significantly in both groups at 1 micro gram/kg/min leptin infusion. Fasting blood glucose and insulin levels decreased significantly at 1 micro gram/kg/min in both the carotid artery group (-10.5% and -82.5%, respectively) and the IV group (-13.6% and -80.4%, respectively). All variables returned to control levels after leptin infusion was stopped. These results indicate that chronic increases in circulating leptin cause sustained increases in arterial pressure and heart rate and are consistent with a possible role for leptin in obesity hypertension. (Hypertension. 1998;31[part 2]:409-414.).

Original languageEnglish (US)
Pages (from-to)409-414
Number of pages6
JournalHypertension
Volume31
Issue number1
DOIs
StatePublished - Jan 1998

Fingerprint

Leptin
Arterial Pressure
Carotid Arteries
Femoral Vein
Catheters
Obesity
Abdominal Aorta
Intravenous Infusions
Central Nervous System
Heart Rate
Hypertension
Sprague Dawley Rats
Blood Glucose
Fasting
Eating
Insulin

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Chronic Leptin Infusion Increases Arterial Pressure. / Shek, Eugene W.; Brands, Michael W.; Hall, John E.

In: Hypertension, Vol. 31, No. 1, 01.1998, p. 409-414.

Research output: Contribution to journalArticle

Shek, Eugene W. ; Brands, Michael W. ; Hall, John E. / Chronic Leptin Infusion Increases Arterial Pressure. In: Hypertension. 1998 ; Vol. 31, No. 1. pp. 409-414.
@article{6c021731a65a450899f10ee8345964d9,
title = "Chronic Leptin Infusion Increases Arterial Pressure",
abstract = "Plasma leptin concentration is increased in hypertensive obese humans, but whether leptin contributes to the increased arterial pressure in obesity is not known. In this study, we tested whether chronic increases in leptin, to levels comparable to those in obesity, could cause a sustained increase in arterial pressure and also the importance of central nervous system (CNS) versus systemic mechanisms. Five male Sprague-Dawley rats were implanted with chronic nonoccluding catheters in the abdominal aorta and both carotid arteries for CNS infusion, and five other rats were implanted with an abdominal aorta catheter and femoral vein catheter for intravenous (IV) infusion. After 7 days of control, leptin was infused into the carotid arteries or femoral vein at 0.1 micro gram/kg/min for 5 days and 1.0 micro gram/kg/min for 7 days, followed by a 7-day recovery period. The carotid artery and IV infusions of leptin at 1 micro gram/kg/min significantly increased plasma leptin levels, from 1.2 +/- 0.4 ng/mL to 91 +/- 5 ng/mL and from 0.9 +/- 0.1 ng/mL to 94 +/- 9 ng/mL, respectively, but there was no significant increase in either group at the low dose. Food intake also did not change at the low dose but decreased by approximately 65{\%} in the carotid group and 69{\%} in the IV group after 7 days of the 1 micro gram/kg/min infusion. Mean arterial pressure (MAP) increased slightly at the low dose only in the carotid group, but this was not statistically significant. At the higher dose, however, MAP increased significantly from 86 +/- 1 mm Hg to 94 +/- 1 mm Hg in the carotid group and from 87 +/- 1 mm Hg to 93 +/- 1 mm Hg in the IV group. Heart rate also increased significantly in both groups at 1 micro gram/kg/min leptin infusion. Fasting blood glucose and insulin levels decreased significantly at 1 micro gram/kg/min in both the carotid artery group (-10.5{\%} and -82.5{\%}, respectively) and the IV group (-13.6{\%} and -80.4{\%}, respectively). All variables returned to control levels after leptin infusion was stopped. These results indicate that chronic increases in circulating leptin cause sustained increases in arterial pressure and heart rate and are consistent with a possible role for leptin in obesity hypertension. (Hypertension. 1998;31[part 2]:409-414.).",
author = "Shek, {Eugene W.} and Brands, {Michael W.} and Hall, {John E.}",
year = "1998",
month = "1",
doi = "10.1161/01.HYP.31.1.409",
language = "English (US)",
volume = "31",
pages = "409--414",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Chronic Leptin Infusion Increases Arterial Pressure

AU - Shek, Eugene W.

AU - Brands, Michael W.

AU - Hall, John E.

PY - 1998/1

Y1 - 1998/1

N2 - Plasma leptin concentration is increased in hypertensive obese humans, but whether leptin contributes to the increased arterial pressure in obesity is not known. In this study, we tested whether chronic increases in leptin, to levels comparable to those in obesity, could cause a sustained increase in arterial pressure and also the importance of central nervous system (CNS) versus systemic mechanisms. Five male Sprague-Dawley rats were implanted with chronic nonoccluding catheters in the abdominal aorta and both carotid arteries for CNS infusion, and five other rats were implanted with an abdominal aorta catheter and femoral vein catheter for intravenous (IV) infusion. After 7 days of control, leptin was infused into the carotid arteries or femoral vein at 0.1 micro gram/kg/min for 5 days and 1.0 micro gram/kg/min for 7 days, followed by a 7-day recovery period. The carotid artery and IV infusions of leptin at 1 micro gram/kg/min significantly increased plasma leptin levels, from 1.2 +/- 0.4 ng/mL to 91 +/- 5 ng/mL and from 0.9 +/- 0.1 ng/mL to 94 +/- 9 ng/mL, respectively, but there was no significant increase in either group at the low dose. Food intake also did not change at the low dose but decreased by approximately 65% in the carotid group and 69% in the IV group after 7 days of the 1 micro gram/kg/min infusion. Mean arterial pressure (MAP) increased slightly at the low dose only in the carotid group, but this was not statistically significant. At the higher dose, however, MAP increased significantly from 86 +/- 1 mm Hg to 94 +/- 1 mm Hg in the carotid group and from 87 +/- 1 mm Hg to 93 +/- 1 mm Hg in the IV group. Heart rate also increased significantly in both groups at 1 micro gram/kg/min leptin infusion. Fasting blood glucose and insulin levels decreased significantly at 1 micro gram/kg/min in both the carotid artery group (-10.5% and -82.5%, respectively) and the IV group (-13.6% and -80.4%, respectively). All variables returned to control levels after leptin infusion was stopped. These results indicate that chronic increases in circulating leptin cause sustained increases in arterial pressure and heart rate and are consistent with a possible role for leptin in obesity hypertension. (Hypertension. 1998;31[part 2]:409-414.).

AB - Plasma leptin concentration is increased in hypertensive obese humans, but whether leptin contributes to the increased arterial pressure in obesity is not known. In this study, we tested whether chronic increases in leptin, to levels comparable to those in obesity, could cause a sustained increase in arterial pressure and also the importance of central nervous system (CNS) versus systemic mechanisms. Five male Sprague-Dawley rats were implanted with chronic nonoccluding catheters in the abdominal aorta and both carotid arteries for CNS infusion, and five other rats were implanted with an abdominal aorta catheter and femoral vein catheter for intravenous (IV) infusion. After 7 days of control, leptin was infused into the carotid arteries or femoral vein at 0.1 micro gram/kg/min for 5 days and 1.0 micro gram/kg/min for 7 days, followed by a 7-day recovery period. The carotid artery and IV infusions of leptin at 1 micro gram/kg/min significantly increased plasma leptin levels, from 1.2 +/- 0.4 ng/mL to 91 +/- 5 ng/mL and from 0.9 +/- 0.1 ng/mL to 94 +/- 9 ng/mL, respectively, but there was no significant increase in either group at the low dose. Food intake also did not change at the low dose but decreased by approximately 65% in the carotid group and 69% in the IV group after 7 days of the 1 micro gram/kg/min infusion. Mean arterial pressure (MAP) increased slightly at the low dose only in the carotid group, but this was not statistically significant. At the higher dose, however, MAP increased significantly from 86 +/- 1 mm Hg to 94 +/- 1 mm Hg in the carotid group and from 87 +/- 1 mm Hg to 93 +/- 1 mm Hg in the IV group. Heart rate also increased significantly in both groups at 1 micro gram/kg/min leptin infusion. Fasting blood glucose and insulin levels decreased significantly at 1 micro gram/kg/min in both the carotid artery group (-10.5% and -82.5%, respectively) and the IV group (-13.6% and -80.4%, respectively). All variables returned to control levels after leptin infusion was stopped. These results indicate that chronic increases in circulating leptin cause sustained increases in arterial pressure and heart rate and are consistent with a possible role for leptin in obesity hypertension. (Hypertension. 1998;31[part 2]:409-414.).

UR - http://www.scopus.com/inward/record.url?scp=0031606279&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031606279&partnerID=8YFLogxK

U2 - 10.1161/01.HYP.31.1.409

DO - 10.1161/01.HYP.31.1.409

M3 - Article

C2 - 9453337

AN - SCOPUS:0031606279

VL - 31

SP - 409

EP - 414

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 1

ER -